{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:55:04Z","timestamp":1790837704244,"version":"4.1.0"},"reference-count":12,"publisher":"The Endocrine Society","issue":"11","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["K08 HD116931"],"award-info":[{"award-number":["K08 HD116931"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Silent corticotroph adenomas (SCAs) are a biologically distinct subset of nonfunctioning pituitary adenomas (NFPAs) characterized by corticotroph lineage without clinical or biochemical evidence of hypercortisolism. Although SCAs exhibit more aggressive growth behavior than other NFPAs, delayed transformation into overt adrenocorticotropic hormone (ACTH)-dependent hypercortisolism is rare. We describe a woman in her early 30s who presented with headaches and visual field deficits and was found to have a pituitary macroadenoma. Initial endocrine evaluation revealed mild hyperprolactinemia attributed to stalk effect, without evidence of hormonal hypersecretion. She underwent transsphenoidal surgery, and pathology was interpreted as an NFPA based on negative immunostaining. Transcription factor analysis was not performed. Postoperative imaging demonstrated a stable 5-mm residual lesion. More than 2 decades after surgery, progressive ACTH elevation emerged despite continued radiographic stability and preceded the development of clinical hypercortisolism by several years. Biochemical testing confirmed ACTH-dependent Cushing disease. Repeat surgery was performed and surgical pathology showed a T-box transcription factor-positive corticotroph adenoma with sparsely granulated ACTH expression. This case highlights the potential for very late functional transformation of SCAs and underscores the importance of long-term clinical and biochemical surveillance even in asymptomatic patients with stable residual disease on imaging.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag301","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:10:11Z","timestamp":1789384211000},"source":"Crossref","is-referenced-by-count":0,"title":["A late awakening: delayed functional transformation of a silent corticotroph adenoma into Cushing disease"],"prefix":"10.1210","volume":"4","author":[{"given":"Nina Maria","family":"Fanaropoulou","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Mass General Brigham, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]},{"name":"Department of Internal Medicine, Miller School of Medicine, University of Miami; Jackson Memorial Hospital , Miami, FL 33136 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1749-8549","authenticated-orcid":false,"given":"Shehzad","family":"Basaria","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Mass General Brigham, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-8624","authenticated-orcid":false,"given":"David M","family":"Meredith","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mass General Brigham, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney W","family":"Woodmansee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of Florida , Gainesville, FL 32611 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R","family":"Smith","sequence":"additional","affiliation":[{"name":"Pituitary Center, Department of Neurosurgery, Mass General Brigham, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9407-6326","authenticated-orcid":false,"given":"George A","family":"Stamatiades","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Mass General Brigham, Harvard Medical School , Boston, MA 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"issue":"2","key":"2026100101590475800_luag301-B1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11102-018-0864-8","article-title":"Silent corticotroph adenomas","volume":"21","author":"Ben-Shlomo","year":"2018","journal-title":"Pituitary"},{"issue":"1","key":"2026100101590475800_luag301-B2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12902-025-02115-8","article-title":"Clinical, radiological, and pathological characteristics and long-term outcomes of silent corticotroph adenomas: a retrospective study","volume":"26","author":"Chen","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"2026100101590475800_luag301-B3","doi-asserted-by":"crossref","DOI":"10.1016\/j.wneu.2025.123791","article-title":"Clinical and radiographic presentation and surgical outcomes of T-box pituitary transcription factor (TPIT) silent corticotroph pituitary neuroendocrine tumors: a multi-institutional experience and review of the literature","volume":"196","author":"Raub","year":"2025","journal-title":"World Neurosurg"},{"issue":"5","key":"2026100101590475800_luag301-B4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1227\/neu.0000000000003512","article-title":"Surgical outcomes of silent ACTH+ corticotroph pituitary neuroendocrine tumors: a multi-institutional experience and review of the literature","volume":"97","author":"Raub","year":"2025","journal-title":"Neurosurgery"},{"issue":"2","key":"2026100101590475800_luag301-B5","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12020-016-1028-0","article-title":"The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1\/3","volume":"56","author":"Righi","year":"2017","journal-title":"Endocrine"},{"issue":"7","key":"2026100101590475800_luag301-B6","doi-asserted-by":"crossref","first-page":"e2362","DOI":"10.1210\/clinem\/dgaf112","article-title":"Cell lineage-specific differences in clinical behavior of non-functioning pituitary adenomas","volume":"110","author":"van der Hoeven","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026100101590475800_luag301-B7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026100101590475800_luag301-B8","article-title":"Clinical parameters of silent corticotroph adenomas with positive and negative adrenocorticotropic hormone immunostaining: a large retrospective single-center study of 105 cases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026100101590475800_luag301-B9","doi-asserted-by":"crossref","DOI":"10.1111\/bpa.13302","article-title":"The 2022 WHO classification of tumors of the pituitary gland: an update on aggressive and metastatic pituitary neuroendocrine tumors","volume":"35","author":"Casar-Borota","year":"2025","journal-title":"Brain Pathol"},{"issue":"2","key":"2026100101590475800_luag301-B10","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.3171\/2014.11.FOCUS14679","article-title":"ACTH adenomas transforming their clinical expression: report of 5 cases","volume":"38","author":"Zoli","year":"2015","journal-title":"Neurosurg Focus"},{"key":"2026100101590475800_luag301-B11","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.558593","article-title":"Clinical, laboratory, and treatment profiles of silent corticotroph adenomas that have transformed to the functional type: a case series with a literature review","volume":"11","author":"Zheng","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2026100101590475800_luag301-B12","doi-asserted-by":"crossref","first-page":"e3346","DOI":"10.1210\/clinem\/dgab387","article-title":"Two distinctive POMC promoters modify gene expression in Cushing disease","volume":"106","author":"Araki","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/11\/luag301\/71540930\/luag301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/11\/luag301\/71540930\/luag301.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:59:19Z","timestamp":1790834359000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag301\/8857140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,9,25]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag301","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,9,25]]},"article-number":"luag301"}}